Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Sai Kiran S.S. Pindiprolu"'
Autor:
Pavan Kumar Chintamaneni, Dasari Nagasen, Katta Chanti Babu, Atul Mourya, Jitender Madan, Dadi A. Srinivasarao, R.K. Ramachandra, P. Madhuri Santhoshi, Sai Kiran S.S. Pindiprolu
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 352
Breast cancer is the most common type of cancer in women and is the second leading cause of cancer-related deaths worldwide. Early diagnosis and effective therapeutic interventions are critical determinants that can improve survival and quality of li
Publikováno v:
RSC Advances. 11:5325-5334
Acetylcholinesterase (AChE) inhibitors such as donepezil, galantamine and rivastigmine are used for the management of dementia in Alzheimer's Disease (AD). These drugs elevate endogenous acetylcholine (ACh) levels at the M1 muscarinic receptor in the
Autor:
Mantosh Kumar Singh, Vidyasrilekha Yele, Bharat Kumar Reddy Sanapalli, G. N. K. Ganesh, Sai Kiran S.S. Pindiprolu
Publikováno v:
International Journal of Biological Macromolecules. 150:631-636
The present research reports the beneficial effects of surface modified chitosan and tumor-homing peptide conjugated liposomes of capecitabine (CAP) for treating breast cancer. Liposomal formulation of CAP was prepared by film hydration method using
Publikováno v:
Medical hypotheses. 157
Triple negative breast cancer (TNBC) is an aggressive form of breast cancer with high rates of tumor relapse and metastasis. The existing drugs for treatment of TNBC are unable to target the cells of origin (breast cancer stem cells) of TNBC. TNF-α
Autor:
Veera Venkata Satyanarayana Reddy Karri, Sivarajakumar Raahulan, Bharat Kumar Reddy Sanapalli, Sai Kiran S.S. Pindiprolu
Publikováno v:
International Journal of Research in Pharmaceutical Sciences. 10:1795-1807
Skin cancer is one of the leading causes of cancer-related deaths worldwide. It is estimated that by 2030, there will be around 13.1million deaths can occur due to skin cancer. Current treatment of skin cancer includes surgery, radiation and chemothe
Autor:
Sai Kiran S.S. Pindiprolu, Aparna Pasula, Nagaraju Madala, Balamurali Raman, Kumara Swamy Battula, Praveen Thaggikuppe Krishnamurthy, Venkata Rao Ghanta
Publikováno v:
RSC Advances. 9:18670-18677
In the present study, novel dermacozine-1-carboxamides (8a–8n) were synthesized and screened for their in vitro cytotoxic activity against three different cancer cell lines: MCF-7 (breast cancer), A-549 (lung cancer) and DU145 (prostate cancer). Al
Autor:
Vidyasrilekha Yele, Bharat Kumar Reddy Sanapalli, Sai Kiran S.S. Pindiprolu, G. N. K. Ganesh, Mantosh Kumar Singh
Publikováno v:
RSC Advances. 9:24987-24994
In the present study, we have formulated a liposomal formulation of cytotoxic agent capecitabine (CAP) to overcome its bioavailability issues. Then we have surface modified CAP loaded liposomes (CAP-LPs) with a tumour homing peptide (THP-CAP-LPs) to
Autor:
Praveen Thaggikuppe Krishnamurthy, Pavan Kumar Chintamaneni, Kusuma Kumari Garikapati, Sai Kiran S.S. Pindiprolu, V.V.V. Ravi Kiran Ammu
Publikováno v:
Nanotechnology in the Life Sciences ISBN: 9783030762629
Breast cancer is one of the principal causes of cancer deaths across the world. Chemoresistance, bioavailability issues and off-target effects are the significant limitations of conventional therapeutic agents in treating breast cancer. In recent yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfc1b0dde7b27b18abf96b00fb55b61f
https://doi.org/10.1007/978-3-030-76263-6_7
https://doi.org/10.1007/978-3-030-76263-6_7
Autor:
Chetan Dev, Pavan Kumar Chintamaneni, Praveen Thaggikuppe Krishnamurthy, Sai Kiran S.S. Pindiprolu
Publikováno v:
Chemistry and physics of lipids. 235
In the present study, Death receptor-5 (DR5) antibody conjugated solid lipid nanoparticles (DR5-DAPT-SLNs) has been formulated for effective intracellular of γ-secretase inhibitor, N-[N-(3,5-Difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl este
Autor:
Mamta Kumari, Sai Kiran S.S. Pindiprolu, Pavan Kumar Chintamaneni, Praveen Thaggikuppe Krishnamurthy, Piyong Sola
Publikováno v:
Expert opinion on drug delivery. 17(8)
α-synuclein (SNCA), a major component of Lewy body is a pathological hallmark of Parkinson's disease (PD). Mutations in the SNCA gene cause misfolding and aggregation of SNCA protein, which results in neurodegeneration. Several studies have establis